checkAd

     101  0 Kommentare Opthea Announces Upcoming Presentations at the Retina World Congress 2024 - Seite 2

    Authorized for release to ASX by Frederic Guerard, CEO

    Investor Inquiries
    PJ Kelleher
    LifeSci Advisors, LLC
    Email: pkelleher@lifesciadvisors.com
    Phone: 617-430-7579

    Media Inquiries
    Silvana Guerci-Lena
    NorthStream Global Partners
    silvana@nsgpllc.com

    Lesen Sie auch

    Join our email database to receive program updates:
    Tel: +61 (0) 3 9826 0399, Email: info@opthea.com Web: www.opthea.com



    globenewswire
    0 Follower
    Autor folgen
    RSS-Feed abonnieren

    Weitere Artikel des Autors

    Seite 2 von 2

    Verfasst von globenewswire
    1 im Artikel enthaltener WertIm Artikel enthaltene Werte
    Opthea Announces Upcoming Presentations at the Retina World Congress 2024 - Seite 2 MELBOURNE, Australia and PRINCETON, N.J., May 01, 2024 (GLOBE NEWSWIRE) - Opthea Limited (ASX/NASDAQ: OPT “Opthea”, the “Company”), a clinical-stage biopharmaceutical company developing novel therapies to treat highly prevalent and progressive …